Challenging the Value of Minimal Residual Disease in Predicting Outcome of Patients With Chronic Lymphocytic Leukemia
J Clin Oncol
.
2023 Jul 20;41(21):3676-3678.
doi: 10.1200/JCO.23.00619.
Epub 2023 Jun 6.
Author
Thomas J Kipps
1
Affiliation
1
Department of Medicine, UC San Diego Moores Cancer Center, University of California, San Diego, San Diego, CA.
PMID:
37279436
PMCID:
PMC10351944
(available on
2024-07-20
)
DOI:
10.1200/JCO.23.00619
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols
Flow Cytometry
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Neoplasm, Residual
Patients
Treatment Outcome